Generate Biomedicines, Inc. Common Stock (GENB) Ownership & Trading Activity
Institutional holders, insider transactions, and congressional trades for GENB. 13F holdings as of 2026-06-30.
In 13F filings for the quarter ended June 30, 2026, 83 institutions reported holding GENB, with 100.0 million shares worth $1.7 billion in aggregate.
Top Institutional Holders
| Institution | Shares | Value | Change |
|---|---|---|---|
| Flagship Pioneering | 62,673,117 | $1.1B | UNCHANGED |
| FMR | 5,221,599 | $88M | INCREASED |
| Capital Group | 4,215,632 | $71M | INCREASED |
| Braidwell | 3,283,844 | $55M | DECREASED |
| T. Rowe Price | 2,156,627 | $36M | INCREASED |
Full institutional holdings, insider history, and congressional trades for Generate Biomedicines, Inc. Common Stock on SentiSense.